Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

LIPOLASIC 2 MG/G GEL OFTALMICO - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/LIPOLASIC 2 MG/G GEL OFTALMICO

Approved

STANDARD

LIPOLASIC 2 MG/G GEL OFTALMICO

Laboratoire Chauvin🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Apr 28, 2025
Approval ID: d5585b880d510778
Company: Laboratoire Chauvin
Type: Standard

Approval Details

Approval Id: d5585b880d510778
Drug Cima Aemps Name: LIPOLASIC 2 MG/G GEL OFTALMICO
Register Number: 3400935931016IP
Holder Company Name: Laboratoire Chauvin
Marketing Company Name: Melyfarma S.L.
Holder Company Detail Path: /organization/7873d0ab8d4a1006/laboratoire-chauvin
Authorization Date: 2025-04-28
Dosage Form: GEL OFTÁLMICO
Dose: 2 mg/g
Route Of Administration: VÍA OFTÁLMICA
Prescription Type: Sin Receta
Commercialized: No
Company Name: Laboratoire Chauvin
Company Detail Path: /organization/7873d0ab8d4a1006/laboratoire-chauvin

Company Information

Pharmaceutical Company Name: LABORATOIRE CHAUVIN
Country Name: France
City Name: aubenas,auvergne rhone alpes,country_fr
Address: ZONE INDUSTRIELLE DE RIPOTIER

Active Ingredients

CARBOMERO

2 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Apr 28, 2025

Approval ID

d5585b880d510778

Type

Standard

Back to CIMA-AEMPS Approvals